Atlas Trials

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Clinical trial NCT07400107 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07400107
Sponsor
Novo Nordisk A/S
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ObesityOverweightDiabetes Mellitus, Type 2
Start date
2026-05-20
Primary completion
2028-12-12
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.